Biological and Pharmaceutical Bulletin · 2013 · 23 citations · 26 references
PharmacyBiotechnologyPharmaceuticsDrug DeliveryGene DeliveryGene TherapyOcular Gene DeliveryOcular Gene TherapyOcular NanocarriersOphthalmic BiomaterialsPolymeric Gene CarriersRetinal Pigment EpitheliumCytotoxicity AssaysGene Therapy Delivery To The VitreousNanoparticle CytotoxicityOcular Drug Delivery BiomaterialsPlasmid Dna VectorsPolymeric Ocular CarriersSafety Of Ocular VectorsToxicity Of Ocular Vectors
In this experiment, we developed anionic ternary complexes for effective and safe ocular gene delivery. Ternary complexes were constructed by coating plasmid DNA (pDNA)/polyethylenimine (PEI) complex with anionic polymers such as γ-polyglutamic acid (γ-PGA) and chondroitin sulfate (CS). The cationic pDNA/PEI complex showed high gene expression on the human retinal pigment epithelial cell line, ARPE-19 cells. The pDNA/PEI complexes, however, also showed high cytotoxicity on the cells and aggregated strongly in the vitreous body. On the other hand, the anionic ternary complexes showed high gene expression on ARPE-19 cells without such cytotoxicity and aggregation. After intravitreous administration of the complexes, the anionic ternary complexes showed high gene expression in the retina. These results strongly indicate that anionic ternary complexes are suitable for effective and safe ocular gene therapy.
26
Gene therapy restores vision in a canine model of childhood blindness
Gregory M. Acland, Jharna Ray, Qí Zhāng et al. · Nature Genetics · 2001 · 1.2K citations
Polyethylenimine-mediated gene delivery: a mechanistic study
Antoine Kichler, Christian Leborgne, Emmanuel Coeytaux et al. · The Journal of Gene Medicine · 2001 · 516 citations
Marika Ruponen, Seppo Ylä‐Herttuala, Arto Urtti · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1999 · 354 citations